Patents by Inventor Haui-Hung Kao

Haui-Hung Kao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxymorphone controlled release formulations
    Patent number: 8329216
    Abstract: The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: December 11, 2012
    Assignee: Endo Pharmaceuticals Inc.
    Inventors: Haui-Hung Kao, Anand R. Baichwal, Troy McCall, David Lee
  • OXYMORPHONE CONTROLLED RELEASE FORMULATIONS
    Publication number: 20070098793
    Abstract: The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.
    Type: Application
    Filed: June 23, 2006
    Publication date: May 3, 2007
    Inventors: Haui-Hung Kao, Anand Baichwal, Troy McCall, David Lee
  • OXYMORPHONE CONTROLLED RELEASE FORMULATIONS
    Publication number: 20070098792
    Abstract: The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.
    Type: Application
    Filed: June 22, 2006
    Publication date: May 3, 2007
    Inventors: Haui-Hung Kao, Anand Baichwal, Troy McCall, David Lee
  • OXYMORPHONE CONTROLLED RELEASE FORMULATIONS
    Publication number: 20070098794
    Abstract: The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.
    Type: Application
    Filed: June 29, 2006
    Publication date: May 3, 2007
    Inventors: Haui-Hung Kao, Anand Baichwal, Troy McCall, David Lee